•
Dec 31, 2019

Axon Q4 2019 Earnings Report

Axon reported a strong finish to 2019 with revenue up 50% and SaaS ARR increased by 49%.

Key Takeaways

Axon's Q4 2019 revenue grew by 50% to $172 million, driven by demand for Axon Body 3, TASER 7, and cloud software. Adjusted EBITDA more than tripled to $38 million, representing a 22% margin.

Record quarterly revenue of $172 million, up 50% year over year, included $26 million of Axon Body 3 hardware shipments.

Adjusted EBITDA was a record $38 million, representing 22% margin on revenue.

Annual recurring revenue grew 49% year over year to $161 million.

Total company future contracted revenue grew to $1.23 billion.

Total Revenue
$172M
Previous year: $115M
+49.7%
EPS
$0.41
Previous year: $0.08
+412.5%
Annual Recurring Revenue
$161M
Future Contracted Revenue
$1.23B
TASER Devices on Recurring Payment Plan
58%
Gross Profit
$92.6M
Previous year: $65.3M
+41.8%
Cash and Equivalents
$172M
Previous year: $349M
-50.7%
Free Cash Flow
$41.9M
Previous year: $27M
+55.3%
Total Assets
$846M
Previous year: $720M
+17.5%

Axon

Axon

Axon Revenue by Segment

Forward Guidance

For the full year 2020, Axon expects to achieve revenue in the range of $615 million to $625 million and Adjusted EBITDA in the range of $100 million to $105 million.

Positive Outlook

  • Revenue in the range of $615 million to $625 million.
  • Q1 2020 revenue will increase approximately 13% year-over-year
  • 2020 revenue will accelerate in the second half of the year, with a back-half weighting similar to 2019.
  • Adjusted EBITDA in the range of $100 million to $105 million.
  • We expect a normalized tax rate of 20% to 25%

Challenges Ahead

  • Adjusted EBITDA guidance reflects modest gross margin improvement over 2019, which will be partially offset by camera hardware shipments to major city customers.
  • Adjusted EBITDA guidance reflects accelerated investments to take advantage of total addressable market expansion opportunities in new product categories.
  • Adjusted EBITDA guidance excludes expected legal costs of up to $15 million associated with litigation involving the FTC, which we intend to treat as an add-back to Adjusted EBITDA.
  • We expect Adjusted EBITDA margin of approximately 10% to 12% in Q1 2020.
  • We are closely monitoring our supply chain and operations in the context of the coronavirus crisis.

Revenue & Expenses

Visualization of income flow from segment revenue to net income